The latest study reveals that cannabis oil has the potential to significantly improve symptoms of Crohn’s disease.
There are many available studies that show people suffering from Crohn's disease frequently use cannabis to gain relief from their symptoms. An Israeli Dr. Timna Naftali, who is a gastroenterologist and a professor at Tel Aviv University, stated that improvement was believed to be associated with a drop in inflammation present in the gut and the study however aimed to investigate the same.
Those who aren’t aware of Crohn’s disease, let us tell you, it is an inflammatory bowel disease (IBD) that remains life-long causing chronic belly pain and diarrhea.
Considering this study as the first of its kind, the study conducted by Dr. Naftali was overall an 8 week treatment plan which included cannabis oil in a 4:1 ratio (CBD and THC). Almost 65% of individuals with Crohn’s disease produced clinical remission. The randomized, placebo-controlled clinical trial consisted of 50 people with moderate to severe forms of Crohn’s disease. The particular group who was treated with cannabis oil had reported a significant enhancement in their quality of life.
Moreover, interestingly cannabis were established to show no result on the gut inflammation that underlies the disease.
Dr. Naftali explained that they have earlier demonstrated that cannabis showed a possible improvement in combating symptoms of Crohn's disease. However, surprisingly, during this study, no statistically significant improvement was seen in the inflammatory or endoscopic scores in the cannabis oil group when compared with the placebo group. It is well known that cannabinoids may show a profound anti-inflammatory effect. However, the study specified that the progression in symptoms may not be associated with the anti-inflammatory properties.
Moving ahead with the research, Dr. Naftali and her team planned to further inspect the potential of cannabis for anti-inflammatory properties to treat Inflammatory Bowel Disease.
The Israeli researcher further stated that there could be grounds to consider that the endocannabinoid system can be a potential therapeutic target for dealing with Crohn's disease and other gastrointestinal disorders. At the moment the researchers could only consider medicinal cannabis as a substitute or an additional intervention to offer short-term relief from the symptom of Crohn's disease.